New Products

View all new products by date added

Search for new products by date added, alphabetically, or by pharmacological action.

New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the symbol.

If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.

Cat No Product Name / Activity Date Added
5914 AM 0902 Oct 2017
Potent and selective TRPA1 antagonist
6102 Ep23, 5'-DY647 Oct 2017
High affinity fluorescently tagged aptamer for EpCam
6310 AZD 1208 Oct 2017
Potent pan Pim kinase inhibitor
6163 AR 420626 Oct 2017
FFA3 agonist
6103 CD133-A15, 5'-DY647 Oct 2017
High affinity fluorescently tagged aptamer for CD133 (AC133 epitope)
6104 CD133-B19, 5'-DY647 Oct 2017
High affinity fluorescently tagged aptamer for CD133 (extracellular domain epitope)
6329 Clozapine N-oxide dihydrochloride Sep 2017
Activator of muscarinic DREADDs
5831 SAR 7334 Sep 2017
Potent TRPC6 inhibitor
6099 Lalistat 2 Sep 2017
Selective lysosomal acid lipase inhibitor
6370 Nor NOHA monoacetate Sep 2017
Arginase inhibitor
6308 PEN (mouse) Sep 2017
GPR83 agonist
6347 PF 04628935 Sep 2017
Potent ghrelin receptor inverse agonist
6346 PF 5006739 Sep 2017
Potent CK1δ/ε inhibitor
6309 PEN (rat) Sep 2017
GPR83 agonist
6307 PEN (human) Sep 2017
GPR83 agonist
5924 ER 819762 Sep 2017
Potent EP4 receptor antagonist; orally bioavailable
6084 ASP 9521 Sep 2017
Potent 17β-hydroxysteroid dehydrogenase type 5 inhibitor;orally bioavailable
6051 G 5555 Sep 2017
High affinity group 1 PAK inhibitor
6075 Nutlin 3a Sep 2017
MDM2 antagonist; active enantiomer of Nutlin-3 (Cat. No. 3984)
5863 PF 04620110 Sep 2017
Potent and selective DGAT-1 inhibitor; orally bioavailable
6345 PF 04991532 Sep 2017
Potent hepatoselective glucokinase activator
6342 Tamoxifen Sep 2017
Estrogen receptor partial agonist/antagonist
6336 Trazodone hydrochloride Sep 2017
5-HT2A and α1 adrenoceptor antagonist; also enhances neural differentiation; antidepressant and neuroprotectant
6192 PZ-II-029 Sep 2017
α6β3γ2-selective GABAA channel modulator
6142 CL 075 Sep 2017
TLR8 agonist
5523 TAPI 0 Sep 2017
ADAM-17 (TACE) and MMP inhibitor
6013 TAPI 2 Sep 2017
ADAM-17 (TACE) and MMP inhibitor
6162 TAPI 1 Sep 2017
ADAM-17 (TACE) and MMP inhibitor
6237 FPS ZM1 Aug 2017
High affinity antagonist of RAGE
6143 WZB 117 Aug 2017
GLUT inhibitor
5956 NF 1819 Aug 2017
Potent and selective irreversible MAGL inhibitor; membrane permeable and brain penetrant
5401 GSK 2250665A Aug 2017
Itk inhibitor
6083 PSB 12379 Aug 2017
Ecto-5'-nucleotidase (CD73) inhibitor
6327 dBET1 Aug 2017
(+)-JQ1 based PROTAC that selectively degrades BRD4 in cells
6240 DG 041 Aug 2017
Potent and selective EP3 antagonist; antiplatelet and antithrombotic
6049 PF 04937319 Aug 2017
Glucokinase partial activator
6048 R-BC154 Aug 2017
High affinity fluorescent α4β1/α9β1 inhibitor; mobilizes HSCs
6196 Brequinar sodium Aug 2017
Potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor
6119 OB 24 hydrochloride Aug 2017
Potent and selective heme oxygenase 1 (HO-1) inhibitor
6230 Rucaparib camsylate Aug 2017
PARP inhibitor
6098 Lalistat 1 Aug 2017
Potent and selective lysosomal acid lipase (LAL) inhibitor
6289 JH-II-127 Aug 2017
Potent and selective LRRK2 inhibitor
5818 NVP BSK 805 Aug 2017
Potent JAK2 inhibitor; orally bioavailable
5705 M62812 Aug 2017
TLR-4 inhibitor
6038 SR 10067 Aug 2017
Selective Rev-Erbα/β agonist; anxiolytic
6193 AM 4113 Aug 2017
Selective, high affinity CB1 antagonist
6278 JNJ 55511118 Aug 2017
Selective, high affinity negative modulator of AMPA receptors containing TARP-γ8
6299 MS 15203 Aug 2017
Potent and selective GPR171 partial agonist
6116 BHPI Aug 2017
ERα antagonist; also activates unfolded protein response; active in vivo
6231 Dacomitinib Jul 2017
Potent irreversible pan ErbB inhibitor
6167 A 196 Jul 2017
Potent and selective SUV420H1/H2 inhibitor
6265 Lonafarnib Jul 2017
Potent farnesyl transferase inhibitor
5768 HS 38 Jul 2017
ATP-competitive inhibitor of DAPK and ZIPK
6016 IN 1130 Jul 2017
Potent and selective inhibitor of TGF-βRI
6078 BPTU Jul 2017
P2Y1 allosteric antagonist
6045 NITD 008 Jul 2017
Antiviral; selective flavivirus inhibitor
6291 ELA-32 (human) Jul 2017
Potent, high affinity apelin receptor agonist; stimulates angiogenesis
6306 BigLEN (rat) Jul 2017
Potent GPR171 agonist
6304 BigLEN (mouse) Jul 2017
GPR171 agonist
6292 ELARR>GG Jul 2017
Negative control for ELA-32 (Cat.No.6291).
6317 Prasugrel Jul 2017
Irreversible P2Y12 antagonist; antiplatelet and orally active
6287 st-Ht31 P Jul 2017
Negative control for st-Ht31 (Cat. No. 6286)
6191 TH 1020 Jul 2017
Toll-like receptor (TLR) 5/Flagellin complex antagonist
6286 st-Ht31 Jul 2017
Inhibits PKA/AKAP interactions; cell permeable
6165 AC 265347 Jul 2017
CaSR biased allosteric modulator
5658 AR-C 141990 hydrochloride Jul 2017
MCT1 inhibitor
6301 Parathyroid hormone (1-34) (rat) Jun 2017
Parathyroid hormone (PTH) receptor agonist
6284 BRD 73954 Jun 2017
Dual histone deacetylase (HDAC) 6/8 inhibitor
6288 Peptide YY (3-36) human Jun 2017
NPY Y2 receptor agonist
6270 Tubastatin A hydrochloride Jun 2017
Potent HDAC6 inhibitor
6128 GSK 343 Jun 2017
Potent and selective SAM-competitive EZH2 inhibitor
6303 Parathyroid hormone (1-34) (bovine) Jun 2017
Parathyroid hormone (PTH) receptor agonist.
6073 P21d hydrochloride Jun 2017
Potent and selective Brk inhibitor
6208 MS 275 Jun 2017
HDAC (Class I) inhibitor
6189 Myricetin Jun 2017
Irreversible TrxR inhibitor
6293 ELA-14 (human) Jun 2017
Potent apelin (APJ) receptor agonist
6302 Pomalidomide Jun 2017
Cereblon ubiquitination inhibitor; also TNF-α inhibitor and antiangiogenic
6294 ELA-14 negative control Jun 2017
Negative control for ELA-14 (Cat.No.6293).
6282 BRD 4770 Jun 2017
G9a inhibitor and S-adenosyl methionine mimetic; cell permeable
4930 UNC 2399 Jun 2017
Biotinylated UNC 1999 (Cat.No. 4904)
5103 Lys-CoA Jun 2017
Selective p300 inhibitor
6185 Pemetrexed Jun 2017
High affinity dihydrofolate reductase inhibitor; also inhibits thymidylate synthase, GARFT and AICART
6174 CVT 313 Jun 2017
cdk2 inhibitor
6277 7α,25-Dihydroxycholesterol Jun 2017
Highly potent GPR183 (EBI2) agonist
6194 TM 5441 Jun 2017
Plasminogen activator inhibitor-1 (PAI-1) inhibitor
6305 Lenalidomide Jun 2017
Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligase
4322 JH 295 May 2017
Irreversible Nek2 inhibitor
5343 TPPB May 2017
High affinity PKC activator; also APP modulator
6311 Tadalafil May 2017
Potent and highly selective PDE5 inhibitor; orally bioavailable
6271 ST 034307 May 2017
Adenylyl cyclase 1 (AC1) inhibitor; analgesic and active in vivo
6258 CC 401 dihydrochloride May 2017
High affinity JNK inhibitor; also inhibits HCMV replication
6181 OTX 015 May 2017
BET bromodomain inhibitor; orally bioavailable
6012 OXSI 2 May 2017
Potent Syk kinase inhibitor; also inhibits assembly of NLRP3 inflammasomes
5675 AZ PFKFB3 26 May 2017
Potent and selective PFKFB3 inhibitor
5821 C-DIM 12 May 2017
Nurr1 activator; inhibits NF-κB-dependent gene expression
6060 AZD 2461 May 2017
Potent PARP inhibitor; orally bioavailable
5921 D9 May 2017
Potent thioredoxin reductase (TrxR) inhibitor
6121 NB-caged Tyrosine hydrochloride May 2017
ortho-nitrobenzyl caged L- tyrosine
5150 NCL 00017509 May 2017
Potent and reversible NIMA related kinase 2 (Nek2) inhibitor
6036 STK16-IN-1 May 2017
Serine/threonine protein kinase 16 (STK16) inhibitor; also inhibits PI 3Kδ, PI 3Kγ and mTOR kinases.
6285 Megestrol Acetate May 2017
Synthetic progesterone analog
5826 LEI 101 hydrochloride May 2017
Potent and selective CB2 partial agonist; orally biovailable
5842 MK 386 May 2017
Potent, selective human type 1 5α-reductase inhibitor
5888 MOPSO, free acid May 2017
Buffer; working pH range in aqueous solution: 6.2-7.6
6061 XMD 8-87 May 2017
Potent Ack1/TNK2 inhibitor
5372 Bioymifi May 2017
DR5 (TRAIL receptor) agonist; induces apoptosis
5963 CMPI hydrochloride May 2017
Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs
6215 H3K4(Me2) (1-20) May 2017
Histone H3 peptide
5452 SKI 178 May 2017
Non-lipid sphingosine kinase 1 (SphK1) inhibitor
3974 Latrunculin B May 2017
Inhibitor of actin polymerization
6259 RAGE antagonist peptide May 2017
RAGE antagonist
6183 Nanchangmycin May 2017
Antiviral; active against Zika, West Nile and dengue viruses
6100 Fasentin May 2017
GLUT1/GLUT4 inhibitor; also Fas-sensitizer
6158 (S)-Equol May 2017
Potent estrogen receptor β (ERβ) agonist; dihydrotestosterone antagonist
6164 SEA 0400 Apr 2017
Potent Na+/Ca2+ exchanger (NCX) inhibitor.
6152 LDN 214117 Apr 2017
Potent and selective ALK2 inhibitor